Background. Malnutrition is closely related to inflammation and atherosclerosis in uraemic patients. There is still debate on how to quantify nutritional status in order to achieve the best prediction of mortality and hospitalization. Methods. Different methods to detect malnutrition were prospectively investigated for their prognostic impact on mortality and hospitalization of haemodialysis (HD) patients. We compared clinical nutrition scores (body mass index, BMI; subjective global assessment, SGA; malnutrition inflammation score, MIS; and nutritional risk screening, NRS) to lab parameters of protein and lipid metabolism, or bioelectrical impedance analysis (BIA) in 90 HD patients. Over a 3-year follow-up, all-cause mortality and hospitalization were evaluated using a Cox regression model. Results. The scores SGA, NRS, MIS, serum albumin, prealbumin, transferrin and BIA were predictive of both mortality and hospitalization. Elevated CRP predicted only a significantly higher mortality. After adjustment for age, gender, dialysis vintage and diabetes status, the best prognostic parameters for mortality were the clinical nutrition scores, MIS-Index ≥ 10 [HR 6.25 (2.82-13.87), P < 0.001], NRS .38), P < 0.001] and SGA B/C [HR 2.70 (1.14-6.41), P < 0.05]. Conclusions. In HD patients, serum markers of protein metabolism and BIA can be used for evaluation of the nutritional status. However, with regard to mortality and hospitalization risk, the individual clinical nutrition scores are superior compared to lab markers and BIA. To confirm malnutrition, we propose using clinical nutrition score generally or at least in the case of two malnutrition-positive parameters (lab, BIA, BMI).
Introduction
Malnutrition is one of the leading risk factors for the development of atherosclerosis and inflammation in patients with end-stage renal disease (ESRD). Up to now the combined occurrence of these three symptoms was referred to as the MIA (Malnutrition-Inflammation-Atherosclerosis) syndrome, which is associated with a high cardiovascular morbidity and mortality among haemodialysis (HD) patients [1] [2] [3] [4] [5] [6] . An expert panel of the International Society of Renal Nutrition and Metabolism (ISRNM) recently recommended the term 'protein-energy wasting', because loss of body protein, fat mass and energy fuel reserves seems to be the major descriptor of this condition [6] .
As we already know, a decreased nutrient intake contributes to a deficiency of antioxidants and vitamins in uraemic patients [7, 8] . Malnutrition further might contribute to enhanced anaemia and erythropoietin resistance, impaired pulmonary function and changes in calciumphosphorus metabolism, but evidence is conflicting [9] [10] [11] [12] [13] .
Several studies revealed the role of clinical assessment, laboratory methods and body composition measurement for diagnosing and quantifying malnutrition. Low body mass index (BMI) and subjective global assessment (SGA) score as simple clinical parameters reliably identify malnutrition [6, 14, 15] . In contrast, evaluation of laboratory markers of protein and lipid metabolism especially in dialysis patients is hampered by the interfering inflammation status. The prognostic value of further parameters, such as BMI, blood pressure, serum concentrations of cholesterol, parathyroid hormone, creatinine and homocysteine, that is well established in the general population cannot be reproduced in ESRD patients, a phenomenon that is referred to as reverse epidemiology [6, [16] [17] [18] .
Serum levels of prealbumin (PRA), already in the early stage of malnutrition, and of albumin (ALB), in later stages of malnutrition, trustworthily verify malnourished HD patients [6, [18] [19] [20] [21] .
Bioelectrical impedance analysis (BIA) is a useful but disputed method for quantifying body composition. In HD Clinical nutrition scores 3813 patients with daily changing hydration status and tissue quality, it is difficult to evaluate malnutrition [6, 18, 22] .
The goal of this investigation was to examine different approaches for the detection of malnutrition and their relative power as predictors for survival and hospitalization of HD patients.
Patients and methods

Subjects
Ninety HD patients from a single outpatient dialysis centre were prospectively observed for 3 years (2003-2006) for mortality and hospitalization. The patients on peritoneal dialysis, with known infections or cardioversion as a BIA contraindication, were excluded. Demographic data of investigated HD patients showed mean age: 61 ± 14 years, mean dialysis vintage: 42 ± 35 months, gender: 53 males and 37 females, and race: 89 Caucasians and 1 African patient. Of the HD patients, 32% were diabetic. Glomerulonephritis (24%), hypertensive nephropathy (17%) and interstitial nephritis (13%) were the other frequent causes of ESRD. In 14% of patients, the primary cause of ESRD was due to rare diseases or unknown. The patients were censored if they received a renal transplant (n = 13) during the study period. No patient was lost to follow-up.
Clinical nutrition scores
For the evaluation of nutritional status BMI and clinical scores SGA, Nutritional Risk Screening (NRS, 2002) and Malnutrition Inflammation Score (MIS) were investigated. BMI was regularly measured at 6-month intervals, whereas SGA, NRS and MIS were determined at study start [23] [24] [25] .
Laboratory parameters
The importance of protein and lipid metabolism for malnourished conditions was tested by six monthly measurements of the serum parameters, total protein, ALB, PRA, transferrin, lipoprotein(a), cholesterol, triglycerides, high (HDL) and low density lipoprotein (LDL). C-reactive protein (CRP) was also assessed 6 monthly for estimation of inflammatory processes. All determined lab markers were evaluated by standard techniques. For prognostic effect on mortality and hospitalization, the baseline levels of the laboratory parameters were considered.
BIA
To measure body composition by bioelectrical impedance, the multifrequency analyser BIA 2000 with software NUTRI 4 (Data Input, Frankfurt, Germany, 1999) was used after HD treatment at study start.
Study procedures
In general, patient therapy was guided by current treatment guidelines [26] [27] [28] [29] [30] . Dialysis therapy was characterized by using biosynthetic polysulfone or polyamide membranes, ultrapure dialysate, bicarbonate oneway cartouches and by radiation or steam-sterilized puncture needles and extracorporal dialysis systems. At baseline and every half-year, dialysis adequacy [31] was measured by urea elimination modelling (Kt/Vsp). As shown in Table 1 , dialysis adequacy, anaemia and bone parameters were optimized during the study process to avoid negative influence of low dialysis efficacy [32] .
Statistical analysis
The clinical events death, hospitalization and their causes were analysed by descriptive statistics. Data of repeated measurements were investigated performing a one-way analysis of variance (ANOVA). Results are expressed as mean ± standard deviation in tabular and diagram. Mortality was analysed using a Cox regression model corrected by age, gender, dialysis vintage and diabetes status. Kaplan-Meier survival graphs were provided. The sample size for this study was calculated as follows: the study should detect predictors for survival and hospitalization at a significance level <0.05 and a power of >0.80 in a one-sided analysis in true hazard ratio of at least 3 over the follow-up period of 3 years. We assumed a median survival of dialysis patients to be 3.8 years as was observed in an earlier study from our group including patients of similar age and comorbidity [33] . To achieve this, at least 81 patients needed to be enrolled (calculated with the online sample size calculator of Schoenfeld DA, Massachusetts General Hospital Mallinckrodt General Clinical Research Center) (http: hedwig.mgh.harvard.edu/biostatistics).
The link between malnutrition and inflammation was tested by Pearson correlation coefficient. Statistics were computed using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA, 2008).
Results
Mortality and hospitalization
During the study period, 16 patients (17.8%) died in the first year, 10 patients (11.1%) in the second and further 10 patients (11.1%) in the third year. Therefore, the total mortality was 40% within 3 years; this met our expectations (sample size calculation based on a median survival of 3.8 years). Cardio-and cerebrovascular events (52%), infections (22%) and malignancies (14%) were the most frequent causes of death.
Hospitalization of patients occurred due to fistula and catheter events (78 admissions, 1220 hospitalization days), infections (47 admissions, 659 hospitalization days), coronary heart disease (30 admissions, 343 hospitalization days) and peripheral arterial occlusive disease (27 admissions, 450 hospitalization days). Altogether 333 hospital admissions (2.4 per patient year) were necessarily, which led to 4679 hospitalization days (14 per admission, 33 per patient year).
Clinical nutrition scores
Neither low mean BMI (Figure 1a ) nor loss of BMI (Figure 1b) during the study was suitable to predict mortality in comparison to all other BMI ranges.
On the other hand, the nutritional scores SGA, NRS and MIS had an excellent prognostic value for mortality (Figure 2a-c) of HD patients.
The hospital admissions and length of stays stratified by nutritional markers are reported in Table 2 . Malnutrition scores SGA B/C, positive NRS, MIS index (≥10; ≥8) increased significantly frequency and duration of hospitalization.
Laboratory parameters
Markers of protein metabolism, such as ALB, PRA (Figure 3a) and transferrin, were significant predictors for mortality. Especially serum levels of ALB and PRA were lower at each time in patients who died during the observation, with significant values at T 6 months (38 ± 7 versus 41 ± 4 g/L; P < 0.05) and T 24 months (36 ± 8 versus 40 ± 4 g/L; P < 0.01) for ALB and at T 0 months (30 ± 10 versus 35 ± 9 mg/dL; P < 0.01) and T 24 months (25 ± 7 versus 35 ± 8 mg/dL; P < 0.01) for PRA. Parameters of lipid metabolism, such as cholesterol, triglycerides, HDL, LDL and lipoprotein(a), however did not influence survival. Elevated pro-inflammatory marker CRP predicted only mortality ( Figure 3b ) and correlated positively with MIS (Pearson R 0.38; P < 0.001) as well as inversely with PRA (R −0.45; P < 0.001), ALB (R −0.31; P < 0.01) and BIA phase angle (R −0.28; P < 0.01). Serum levels of ALB (≤ 35 g/L), PRA (≤ 20 mg/dL) and transferrin (≤ 160 mg/dL) were also significant predictors for the need for hospitalization (Table 2 ). For increased CRP (≥ 10 mg/L) and decreased cholesterol (≤ 3.5 mmol/L) serum concentration, a trend for a higher hospitalization rate can be supposed.
BIA
Bioelectrical phase angle (Figure 3c ) and body cell mass (P = 0.05) were prognostic factors for survival and hospital admissions (only frequency) of HD patients, with the best prognosis being predicted by the highest phase angle. The other parameters of body composition, especially ratio of fat and water to body weight, were not predictive. 
Comparison of predictors
As shown in Table 3 , clinical nutrition scores, in the order of MIS (≥ 10; ≥ 8), NRS and SGA, were the best predictors for survival compared to the other methods for assessment of nutritional status. For the hospitalization rate the markers of protein metabolism ALB, PRA (only admissions) and transferrin had a similar prognostic value as the clinical nutrition scores. A specificity for malnutrition over 80% with high mortality risk is demonstrable by a combination of two suitable parameters (Table 4) .
Discussion
Malnutrition or protein-energy wasting is a relevant problem in dialysis patients. It is associated with an increased risk of mortality, morbidity and hospitalization [6, 21, 34] . This prospective study was performed to evaluate the clinical importance of different nutritional markers with regard to the prediction of mortality and hospitalization. The causes and frequency of mortality and morbidity were similar to those that were recently described by Mauri et al. [35] . The nutritional markers were compared to the wellestablished parameter of chronic inflammatory response in ESRD, the CRP serum level. Our study shows that malnutrition assessed by clinical examination scores (MIS, NRS, SGA), protein markers (ALB, PRA, transferrin) and BIA phase angle and inflammation assessed by CRP serum levels are connected and associated with increased mortality in HD patients. On the other hand, prognostic factors for hospitalization are the clinical examination scores and the protein markers ALB, PRA (only admissions) and transferrin, whereas the elevated CRP serum concentration was not significantly predictive. These results supplement data from other studies [1, 19, 21, 25, [36] [37] [38] [39] [40] ; however, we are the first to compare a broad spectrum of parameters (4 physical examination scores, 10 laboratory parameters, multifrequency BIA) in a 3-year prospective study. All other combinations including hospitalization (days, frequency) had lower specifity for malnutrition.
Recent reports [41, 42] questioned the usefulness of the SGA score for detection of malnutrition in the sense of reduced food and energy uptake. It remains uncertain whether or not the reduced consumption and resorption of food are the relevant causes of the alterations measured by SGA. However, we could detect a significant elevation of mortality and hospitalization with abnormal assessment results similar to data from Hung CY et al. [38] . When using NRS and MIS, an even higher risk especially for mortality could be verified. Nevertheless multidimensional MIS, recently known as a strong mortality predictor [36] , is simple to perform and now confirmed by this study also superior for the prediction of survival in HD patients compared to all other investigated assessment methods. Moreover, brandnew data [36, 43, 44] showed an increase of mortality risk and restricted quality of life with elevating MIS.
Among the single laboratory markers, only ALB, PRA, transferrin and CRP are reliable prognostic parameters. In particular, dyslipidaemia could not be verified as a predictor for decreased survival. Data from Wanner C et al. [45] support the thesis that dyslipidaemia, even with therapy, does not affect mortality in HD patients.
The measurement of bioelectrical impedance may be used for the detection of malnutrition as well as the body fluid status. It was therefore relevant to test whether a lower phase angle as the read-out of BIA might be predictive for mortality and hospitalization. Such decreased phase angle may be indicative of either malnutrition or overhydration. It is remarkable that a significant prediction of mortality remained in spite of this uncertainty. A significant impact on hospitalization could only be demonstrated for frequency, and not for length of hospital admissions. This might be explained by the interference of overhydration, although BIA assessment was done after the HD session. Potentially, the problem could be overcome by detecting the phase angle in a BIA vector graph, a method to improve the separation between fluid and nutritional status [40] .
In conclusion, our prospective trial shows that physical examination scores detect the adverse prognostic effect of malnutrition or protein energy wasting more reliably than single laboratory parameters. However, the best method to diagnose malnutrition is the regular determination of clinical nutrition parameters, but this is time consuming and not practical in everyday dialysis. Therefore, our algorithm suggests the use of clinical nutrition score at least in the case of two malnutrition-positive technical parameters (lab, BIA, BMI). We recommend that the selection of patients for nutritional supplementation or other types of intervention should be mainly based on examination scores. Effects of nutritional advice and therapy as a long-term option will be tested in the prospective Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study [46] .
